e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mortality risk prediction in COPD by a prognostic biomarker panel
Stolz Daiana, Meyer Anja, Rakic Janko, Boeck Lucas, Scherr Andreas, Tamm Michael
Source:
Eur Respir J 2014; 44: 1557-1570
Journal Issue:
December
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Stolz Daiana, Meyer Anja, Rakic Janko, Boeck Lucas, Scherr Andreas, Tamm Michael. Mortality risk prediction in COPD by a prognostic biomarker panel. Eur Respir J 2014; 44: 1557-1570
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up
Source: International Congress 2014 – Markers
Year: 2014
Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index.
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
Pro-adrenomedullin is a predictive marker for all-cause mortality in stable COPD: An analysis of the COSYCONET study
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2
Year: 2020
Risk factor biomarker differences in rehospitalization for patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 838s
Year: 2006
Blood biomarker algorithms to guide COPD assessment and risk stratification
Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Year: 2017
Validation of bode index as a predictor of mortality in COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
Mortality and prognostic factors in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score
Source: Eur Respir J, 49 (6) 1602191; 10.1183/13993003.02191-2016
Year: 2017
Pilot: identification of rehospitalization risk factors for patients with COPD
Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Year: 2005
Analysis of NEWS2 trend to predict risk of death in COPD
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020
COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020
Cluster phenotyping as an approach to identify COPD patients at risk of poor prognosis.
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Microalbuminuria as a potential novel cardiovascular biomarker in patients with COPD
Source: Eur Respir J 2014; 43: 951-953
Year: 2014
Predictive factors of mortality in COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 76s
Year: 2007
Mortality after hospitalisation for COVID19, and identification of prognostic factors on admission that increase mortality risk
Source: Virtual Congress 2021 – COVID - 19
Year: 2021
Predictive modelling of COPD exacerbation rates using baseline risk factors
Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Year: 2020
Evaluation of DECAF, CURB-65 and BAP-65 scales as predictor of mortality risk in acute exacerbation of COPD in a retrospective cohort
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017
Prognostic values of biomarkers in COPD
Source: Annual Congress 2013 –Natural history of COPD: novel aspects
Year: 2013
Pro-adrenomedullin as prognostic marker in patients with CAP
Source: Annual Congress 2008 - Improved diagnosis and clinical decision-making by integrating information from new biomarkers
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept